Clinical Trial Update: Schizophrenia Treatment With Photoneuromodulation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating photoneuromodulation for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Photoneuromodulation therapy device

Snippet

Sponsor: University of Sao Paulo | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED